BioCentury | Feb 5, 2021
Emerging Company Profile
Deals with Allogene, ADC reflect Overland’s ambition to tap parent Hillhouse’s network to bring innovation to China
Backed by Hillhouse’s deep pockets, Overland aims to leverage its parent firm’s biopharma ecosystem in China to bring first-in-class and best-in-class Western therapies to the country. Overland Pharmaceuticals launched...